About Nodal Therapeutics
Nodal Therapeutics is a private company based in Silver Spring, Maryland, incorporated in 2024 in Delaware. It has reported $250,000 raised in one offering on Form D since June 2024. Its chief executive is Christopher Jewell.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 23, 2024 | Jun 6, 2024amended Oct 29, 2024 | $250,000fully sold | 1 | $250K | Equity, Simple Agreement for Future EquityRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Nodal Therapeutics's Form D filed Oct 29, 2024.
JB
Jonathan Bromberg
Executive officer
CJ
Christopher Jewell
Chief Executive Officer and director